Israel faces tough choices on medical cannabis market – MMJDaily
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Why This Matters Licensed cannabis cultivation reduces illegal market activity, which is…
Survey: Americans Microdose Cannabis Far More Than Psychedelics – Ganjapreneur
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchDosingMental HealthAnxiety Why This Matters Clinicians should understand that cannabis microdosing is becoming a…
‘Fitness, fresh air and forward thinking’: Cape to Cape for Cannabis delivers a new kind of …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryPolicy Clinical Summary # Cannabis Clinical Summary Medical Cannabis Research Australia (MCRA) organized…
DOJ Reschedules Medical Marijuana: Implications For Insurance Coverage, Capacity, And …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Why This Matters The DEA's rescheduling of cannabis from Schedule I to Schedule III removes a…
Will the Medical Cannabis Market Grow as More Countries Approve
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Why This Matters As more countries approve medical cannabis based on emerging clinical evidence,…
What Doctors Want You to Know About Cannabis and Health – The New York Times
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyAgingPainAnxiety Why This Matters Clinicians need current evidence on cannabis safety and efficacy in…
Medical Marijuana Reclassification: New Research Opportunities – Observer Voice
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMedical Cannabis Why This Matters Reclassification of cannabis as a lower-controlled substance enables…
The Future of Clinical Research: Why Innovation Must Be Matched with Accountability
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyPolicyIndustry Clinical Summary # Clinical Summary The accelerating development of cannabinoid-based…
What we know—and what we don’t—about marijuana’s health effects | Scientific American
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCCBDMental Health Why This Matters Clinicians need current evidence about cannabis’s health…
France’s Medical Cannabis Trial: 3% Serious Adverse Events in 3,164 Patients Over Three Years
During the experimentation, 3% of patients treated with MC experienced at least one serious ADR. The safety profile was dominated by neurological, gastrointestinal, and psychiatric ADRs. Only one case of MC misuse was identified with inflorescences. This…